640 related articles for article (PubMed ID: 26072112)
21. The Prognostic Value of Serum Levels of Heart-Type Fatty Acid Binding Protein and High Sensitivity C-Reactive Protein in Patients With Increased Levels of Amino-Terminal Pro-B Type Natriuretic Peptide.
Jeong JH; Seo YH; Ahn JY; Kim KH; Seo JY; Kim MJ; Lee HT; Park PW
Ann Lab Med; 2016 Sep; 36(5):420-6. PubMed ID: 27374706
[TBL] [Abstract][Full Text] [Related]
22. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
[TBL] [Abstract][Full Text] [Related]
23. Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failure.
Baggish AL; van Kimmenade RR; Januzzi JL
Am J Cardiol; 2008 Feb; 101(3A):49-55. PubMed ID: 18243859
[TBL] [Abstract][Full Text] [Related]
24. The additive value of N-terminal pro-B-type natriuretic peptide testing at the emergency department in patients with acute dyspnoea.
van der Burg-de Graauw N; Cobbaert CM; Middelhoff CJ; Bantje TA; van Guldener C
Eur J Intern Med; 2009 May; 20(3):301-6. PubMed ID: 19393498
[TBL] [Abstract][Full Text] [Related]
25. Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study.
Anwaruddin S; Lloyd-Jones DM; Baggish A; Chen A; Krauser D; Tung R; Chae C; Januzzi JL
J Am Coll Cardiol; 2006 Jan; 47(1):91-7. PubMed ID: 16386670
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the diagnostic and prognostic values of B-type and atrial-type natriuretic peptides in acute heart failure.
Seronde MF; Gayat E; Logeart D; Lassus J; Laribi S; Boukef R; Sibellas F; Launay JM; Manivet P; Sadoune M; Nouira S; Solal AC; Mebazaa A;
Int J Cardiol; 2013 Oct; 168(4):3404-11. PubMed ID: 23684562
[TBL] [Abstract][Full Text] [Related]
27. Quantifying cardiac hemodynamic stress and cardiomyocyte damage in ischemic and nonischemic acute heart failure.
Drexler B; Heinisch C; Balmelli C; Lassus J; Siirilä-Waris K; Arenja N; Socrates T; Noveanu M; Potocki M; Meune C; Haaf P; Degen C; Breidthardt T; Reichlin T; Nieminen MS; Veli-Pekka H; Osswald S; Mueller C
Circ Heart Fail; 2012 Jan; 5(1):17-24. PubMed ID: 21976469
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic utility of N-terminal-proBNP in differentiating acute pulmonary embolism from heart failure in patients with acute dyspnea.
Guo L; Li G; Wang Y; Liang H; Shan X; Zhang N; Wang M; Lin D; Zhu L
Chin Med J (Engl); 2014; 127(16):2888-93. PubMed ID: 25131222
[TBL] [Abstract][Full Text] [Related]
29. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
30. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528
[TBL] [Abstract][Full Text] [Related]
31. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study.
Januzzi JL; Chen-Tournoux AA; Christenson RH; Doros G; Hollander JE; Levy PD; Nagurney JT; Nowak RM; Pang PS; Patel D; Peacock WF; Rivers EJ; Walters EL; Gaggin HK;
J Am Coll Cardiol; 2018 Mar; 71(11):1191-1200. PubMed ID: 29544601
[TBL] [Abstract][Full Text] [Related]
32. [Prognostic value of N-terminal-pro-brain natriuretic peptide on admission in patients with chronic heart failure].
Wang F; Li W; Huang J; Wang L; Bian WY; Pang HM; Wang Y; Xu ZM; Li YS
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Jan; 34(1):28-32. PubMed ID: 16626545
[TBL] [Abstract][Full Text] [Related]
33. Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department.
Januzzi JL; Sakhuja R; O'donoghue M; Baggish AL; Anwaruddin S; Chae CU; Cameron R; Krauser DG; Tung R; Camargo CA; Lloyd-Jones DM
Arch Intern Med; 2006 Feb; 166(3):315-20. PubMed ID: 16476871
[TBL] [Abstract][Full Text] [Related]
34. Improving the diagnosis of acute heart failure using a validated prediction model.
Steinhart B; Thorpe KE; Bayoumi AM; Moe G; Januzzi JL; Mazer CD
J Am Coll Cardiol; 2009 Oct; 54(16):1515-21. PubMed ID: 19815122
[TBL] [Abstract][Full Text] [Related]
35. Analyzing Dynamic Changes of Laboratory Indexes in Patients with Acute Heart Failure Based on Retrospective Study.
Wang Y; Fu L; Jia Q; Yu H; Zhang P; Zhang C; Huang X; He K; Tian Y
Biomed Res Int; 2016; 2016():7496061. PubMed ID: 27144175
[TBL] [Abstract][Full Text] [Related]
36. Bioelectrical impedance analysis for heart failure diagnosis in the ED.
Génot N; Mewton N; Bresson D; Zouaghi O; Francois L; Delwarde B; Kirkorian G; Bonnefoy-Cudraz E
Am J Emerg Med; 2015 Aug; 33(8):1025-9. PubMed ID: 25959843
[TBL] [Abstract][Full Text] [Related]
37. Association of NT-proBNP with severity of heart valve disease in a medical patient population presenting with acute dyspnea or peripheral edema.
Behnes M; Lang S; Breithardt OA; Kaden JJ; Haghi D; Ahmad-Nejad P; Elmas E; Wolpert C; Borggrefe M; Neumaier M; Brueckmann M
J Heart Valve Dis; 2008 Sep; 17(5):557-65. PubMed ID: 18980090
[TBL] [Abstract][Full Text] [Related]
38. Growth differentiation factor-15 combined with N-terminal prohormone of brain natriuretic peptide increase 1-year prognosis prediction value for patients with acute heart failure: a prospective cohort study.
Hao J; Cheang I; Zhang L; Wang K; Wang HM; Wu QY; Zhou YL; Zhou F; Xu DJ; Zhang HF; Yao WM; Li XL
Chin Med J (Engl); 2019 Oct; 132(19):2278-2285. PubMed ID: 31567379
[TBL] [Abstract][Full Text] [Related]
39. The use of discharge haemoglobin and NT-proBNP to improve short and long-term outcome prediction in patients with acute heart failure.
Stojcevski B; Celic V; Navarin S; Pencic B; Majstorovic A; Sljivic A; Magrini L; Cristofano F; Cavalieri L; Di Somma S;
Eur Heart J Acute Cardiovasc Care; 2017 Dec; 6(8):676-684. PubMed ID: 25943556
[TBL] [Abstract][Full Text] [Related]
40. Influence of glycosylation on diagnostic and prognostic accuracy of N-terminal pro-B-type natriuretic peptide in acute dyspnea: data from the Akershus Cardiac Examination 2 Study.
Røsjø H; Dahl MB; Jørgensen M; Røysland R; Brynildsen J; Cataliotti A; Christensen G; Høiseth AD; Hagve TA; Omland T
Clin Chem; 2015 Aug; 61(8):1087-97. PubMed ID: 26056354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]